Effectiveness and safety of reduced-dose fluoropyrimidine therapy in patients carrying the DPYD*2A variant: A matched pair analysis

Author(s):
Henricks, L.M. (0000-0003-0141-7927); Merendonk, L.N. van; Meulendijks, D.; Deenen, M.J.; Beijnen, J.H.; Boer, A. de; Cats, A.; Schellens, J.H.M.
Published
2019
Publication type
Article / Letter to editor
DPYDdihydropyrimidine dehydrogenasefluoropyrimidines5-fluorouracilcapecitabine
Date issued
2019-05-01
Language
English
Is part of
International Journal of Cancer (2019), Vol. 144, no. 9, p. 2347-2354
hdl
1887/120039
doi
10.1002/ijc.32022